ITEMS IN AFP WITH KEYWORD:
Sep 15, 2020 Issue
Screening for Hepatitis C Virus Infection in Adolescents and Adults: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends screening for hepatitis C virus infection in adults aged 18 to 79 years.
Sep 15, 2020 Issue
Screening for Hepatitis C Virus Infection in Adolescents and Adults [Putting Prevention into Practice]
M.S. is a 20-year-old man who presents for a preemployment physical examination. He states that he is single, has two or three drinks per month on social occasions, does not smoke, is sexually active, and does not use illicit drugs.
Jan 1, 2020 Issue
Branched-chain Amino Acids for Patients with Hepatic Encephalopathy [Medicine by the Numbers]
Hepatic encephalopathy is a brain dysfunction that can be mild with minimal confusion, or overt and severe with coma. Learn more about branched-chain amino acids for the treatment of hepatic encephalopathy.
Patient story about being diagnosed with hepatitis C and successful treatment by family doctor.
Screening for hepatitis B is recommended in pregnant women at their first prenatal visit and in adolescents and adults at high risk of chronic infection. Individualized treatment plans should take into account clinical and laboratory characteristics and risk of cirrhosis and hepatocellular carcinoma. Peginterferon alfa-2a, entecavir, and tenofovir are considered first-line treatment options. Vaccination is recommended for appropriate patients.
Glecaprevir/pibrentasvir is an effective treatment for any of six genotypes of HCV infection and has few adverse effects. It can be used to treat more genotypes over a shorter duration (eight weeks for patients without cirrhosis) and is substantially less expensive than other available treatments.
The Centers for Disease Control and Prevention encourages family physicians to treat patients with hepatitis C. Outcomes when primary care physicians prescribe direct-acting antivirals to patients with uncomplicated hepatitis C are comparable to those of subspecialists.
The American College of Physicians and Centers for Disease Control and Prevention highlights the consensus among these recommendations, with recent evidence, to develop a best practice advice statement for vaccination, screening, care, and treatment of patients at risk of or who currently have HBV infection.
Jun 1, 2017 Issue
Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C [Medicine by the Numbers]
Although they help patients achieve sustained viralogic response, expensive direct-acting antivirals have yet to show that they can succeed in meeting top-priority treatment goals.
Sofosbuvir/velpatasvir is an effective treatment for patients with HCV and has minimal adverse effects. It is the preferred treatment for patients with genotype 2 or 3. As with other curative treatments, it is very expensive.